RFK Jr.’s Seven-Hearing Hill Marathon: April 16–22, 2026
Robert F. Kennedy Jr.’s late-April swing through Congress was not one hearing but a seven-stop stress test of his second-year leadership of HHS. The hearings ranged across House and Senate authorizers and appropriators: Ways & Means, House Appropriations, Energy & Commerce, Senate Appropriations, Senate Finance, and Senate HELP. The master file lists the seven events, their dates, committees, topics, and video links; despite the file title’s “April 14 to April 22” framing, the seven hearings documented in the source set begin on April 16 and run through April 22.
The result was a compressed portrait of Kennedy’s HHS: ambitious, disruptive, rhetorically potent, and politically combustible. His message was consistent. America is sick; the old health system is broken; HHS has been captured by profit-driven and status-quo institutions; chronic disease, nutrition, fraud, rural hospital decline, drug prices, and bureaucratic friction must be attacked at the root. He repeatedly framed the department’s agenda as a generational correction, including food policy, prior authorization, rural health, faster FDA approvals, ultra-rare disease programs, drug pricing, and fraud enforcement. In his own Ways & Means opening, he said the country was at a “generational turning point,” that children were the “sickest generation in modern history,” and that HHS was replacing policies that fueled chronic disease with policies that put Americans’ health first.
But the hearings also showed the limits of that message. Democrats repeatedly focused on vaccines, measles, CDC changes, NIH and CDC cuts, Medicaid reductions, contraception, grant terminations, and whether Kennedy’s public-health worldview had moved from skepticism into governance. Republicans, by contrast, often treated him as the rare cabinet officer who was willing to say the system was rotten and needed to be rebuilt. The result was a week in which Kennedy’s strengths and weaknesses were almost identical: he was most effective when talking broadly about incentives, chronic disease, rural care, and fraud; he was weakest when cornered on precise yes/no policy commitments, technical details, or scientific claims.
 |
| click to enlarge |
Document 01 — April 16, House Ways & Means: The Full MAHA Framing
The first major hearing, before House Ways & Means, was the broadest and in some ways the most revealing. The chairman’s opening framed Kennedy as a central figure in the Trump administration’s Make America Healthy Again movement. The committee’s Republican narrative was that the United States spends $5.3 trillion annually on health care while getting worse outcomes, that six in ten Americans have at least one chronic disease, and that the payment system rewards illness more than prevention. The chairman also tied Kennedy’s agenda to rural health, consolidation, Medicare fraud, and the $50 billion rural health transformation program.
Kennedy’s own prepared statement then turned those themes into a governing manifesto. He claimed HHS had negotiated most-favored-nation drug prices with major pharmaceutical firms, pressed health insurers on prior authorization, issued new dietary guidelines focused on “real whole food,” pushed medical schools to expand nutrition education, promoted natural food colorings, strengthened infant formula safety, and directed $50 billion over five years to rural health. He used the familiar Kennedy-family note as well, quoting President John F. Kennedy on change having enemies.
The Democratic counter-frame came early from Ranking Member Neal, who invoked Massachusetts, the Kennedy family, NIH, CDC, vaccines, Boston’s biomedical ecosystem, and even Dunkin’ Donuts coffee. His point was pointed: Kennedy was not merely reforming a broken system; from the Democratic view, he was threatening a bipartisan public-health and biomedical-research infrastructure built over decades. Neal’s line that no candidate ever runs saying “Vote for me, I’m for more fraud” neatly captured the Democratic complaint: anti-fraud rhetoric is easy; program cuts and public-health disruption are the real issue.
This first hearing established the week’s recurring dynamic. Kennedy could deliver a powerful, populist anti-status-quo message, but the hearing immediately split into two different definitions of “status quo.” For Republicans, the status quo was chronic disease, insurer power, hospital consolidation, processed food, and fraud. For Democrats, the status quo Kennedy was threatening was vaccination, NIH, CDC, Medicaid, LIHEAP, child care, and mainstream biomedical science.
Document 02 — April 16, House Appropriations Labor-HHS: Budget Meets Culture War
The second April 16 hearing, before the House Appropriations Labor-HHS-Education Subcommittee, put the same agenda inside a stricter appropriations frame. The hearing file notes that the YouTube version lacked a clean transcript link and that the text came from an Otter transcript, which is important because the source is rougher than the others.
The Republican opening praised Kennedy for challenging the assumption that more health spending automatically produces better health. It linked MAHA to chronic disease, rural health, NIH, conscience protections, and opposition to gender-related surgeries for minors. The chairman also acknowledged a tension that would recur all week: he supported NIH and warned that “extreme swings” in biomedical research funding could be counterproductive, even while accepting that Kennedy had been asked to meet the President’s budget objectives.
Ranking Member DeLauro’s opening was more complicated. She actually praised Kennedy on microplastics, saying she had spoken with him and applauded HHS and EPA efforts to classify microplastics as water contaminants. But she then turned sharply to budget cuts, accusing the administration of proposing a $16.5 billion cut to health agencies, defunding Medicaid and nutrition assistance, firing personnel, and damaging CDC, SAMHSA, and AHRQ.
The most memorable exchange concerned raw milk. DeLauro pressed Kennedy on whether, as HHS Secretary, he had a moral responsibility to say plainly that people should not drink raw milk because it can be dangerous. Kennedy responded that raw milk is regulated by states, not the federal government, and that HHS informs the public. DeLauro’s answer was blunt: if she were HHS Secretary, she would “by God” say not to drink raw milk.
This hearing showed a subtle problem for Kennedy. His “inform the public, restore choice, challenge orthodoxy” approach is politically attractive to supporters. But for public-health traditionalists, it can sound like the Secretary of Health declining to say the obvious thing. That became a larger metaphor for vaccines.
Document 03 — April 21, House Energy & Commerce Health Subcommittee: The Hardest Cross-Examination
The House Energy & Commerce Health Subcommittee hearing was among the sharpest. It opened in the source file with an aggressive contraception exchange. Kennedy was asked whether HHS would commit not to limit access to a patient’s chosen birth-control method. Instead of a direct answer, he pivoted to maternal health, asserting that the administration had done more for maternal health than any prior administration and citing a perinatal pilot program. The member concluded that he had refused to tell American women whether he would protect access to contraception.
On rural health, Kennedy had stronger footing. He described rural hospital closures as an epidemic, said 120 rural hospitals had closed since 2010, and argued that the administration’s rural health investment was the largest in U.S. history. He framed the $50 billion program as a way to rebuild infrastructure, recruit and retain workers, and bring technology, AI, and telehealth to rural communities.
Fraud gave him another strong lane. He attacked “pay and chase,” saying the prior approach paid claims known to be fraudulent and then attempted to claw the money back later. He cited ABA therapy fraud in Minnesota and a Florida hotel allegedly housing 129 durable medical equipment companies, none of which had sold DME.
But the hearing turned punishing on vaccines. One member pressed him on the hepatitis B birth-dose recommendation, asking whether he knew the false-negative rate for maternal testing. Kennedy acknowledged that the test makes mistakes but said he was not sure of the error rate. Another member accused him of creating doubt about medicine and science, linking his policies to parents refusing vitamin K and vaccines, and said his legacy could be “the HHS secretary that caused kids to die.”
This hearing exposed Kennedy’s most consistent weakness: when a member had a technically precise clinical question, Kennedy often tried to widen the frame. Sometimes that was rhetorically effective; sometimes it looked evasive.
Document 04 — April 21, House Ways & Means: Medicare Fraud as Political Theater and Policy Problem
The second House Ways & Means hearing on April 21 was devoted to Medicare fraud. The master file notes an important correction: one YouTube link was only a four-minute clip; the correct full hearing link was a different YouTube video.
The hearing’s Republican frame was dramatic. Medicare was described as a promise earned by Americans who worked and paid into the system, now threatened by fraudsters, transnational criminals, fake hospices, DME scams, and state-level failures. The opening cited Los Angeles County hospice concerns, a 1,500% rise in hospice facilities from 2010 to 2022, one building allegedly housing 89 hospices, and Medicare losing roughly $60 billion per year to fraud, waste, and abuse.
Democrats agreed fraud mattered but attacked the administration’s selectivity. Ranking Member Doggett argued that tough talk is not a substitute for enforcement. He focused on the reinstatement of 850 agents and brokers previously suspended for suspected fraud, saying Kennedy and CMS Administrator Dr. Oz had been unable to confirm whether those brokers were investigated or monitored after reinstatement. He also argued that ACA marketplace fraud was committed by agents and brokers, not patients seeking care.
The best testimony in this hearing may not have been partisan at all. A fraud victim described the human consequences of being wrongly enrolled in hospice and having Medicare access disrupted. She said she received no apology, no meaningful acknowledgement, and only later saw a notice that her hospice election had been removed. She compared the needed response to credit-card fraud: once fraud is identified, put it in dispute, protect the victim, communicate, and help the person through the process.
The strongest policy phrase from the hearing was: “fraud pays.” One witness argued there were not enough safeguards to prevent sham agencies from becoming Medicare providers, and called for site visits, beneficiary surveys, and better claims-data anomaly detection.
This hearing was important because it showed fraud as both real and politically overdetermined. Kennedy’s anti-fraud message is one of his most durable, but the implementation questions remain: prepayment review, provider enrollment, NPI deactivation, data systems, beneficiary remediation, and how to avoid turning anti-fraud tools into blunt access barriers.
Document 05 — April 21, Senate Appropriations Labor-HHS: Appropriators Want Answers, Not Slogans
The Senate Appropriations Labor-HHS hearing was more sober. Chair Capito opened by noting that this was Kennedy’s fifth of seven hearings and joked that he should be “all warmed up.” She praised the reversal of questionable SAMHSA grant cancellations, emphasized NIH’s bipartisan support, and raised rural health and HRSA’s proposed move into the new Administration for a Healthy America. She also noted that answers to the prior year’s questions for the record had arrived almost nine months later, far beyond the 45-business-day statutory requirement.
Vice Chair Baldwin’s opening was severe. She argued the budget proposed a $17 billion, or 14%, cut to HHS programs under the subcommittee’s jurisdiction; a nearly $6 billion NIH cut; a one-third cut to CDC programs; and a nearly $1 billion, or more than 68%, cut to CDC’s chronic disease center. She also accused the administration of delaying grants, reducing NIH funding opportunities, and harming research in cancer, Alzheimer’s, ALS, diabetes, mental health, and other diseases.
Kennedy had one unusually effective moment here because he admitted error. When asked about SAMHSA grant terminations, he said he did not approve them, called them a mistake and an “overcorrection,” and said he reversed them within 24 hours after learning about them.
That admission was probably one of his best moments of the week. It was not ideological. It was managerial. He conceded a problem, described it as an overcorrection, and said he fixed it. In a week of accusation and counteraccusation, that stood out.
But the same hearing also showed how appropriators can press where authorizers posture. Kennedy’s broad statements about chronic disease ran into specific questions about diabetes, CDC education programs, Native American diabetes funding, and a diabetes-and-dementia study tied up in a dispute with Columbia University. He said he did not want to cut diabetes research, but his answer did not fully address the budget contradiction.
Document 06 — April 22, Senate Finance: Drug Pricing, Medicaid, Vaccines, and the Limits of Combativeness
The Senate Finance Committee hearing was perhaps the most politically consequential. Chairman Crapo opened with a Republican narrative of Medicaid reform, PBM reform, telehealth, hospital-at-home, rural health, prior authorization, TrumpRx, and the shift toward prevention and “whole person” care.
Ranking Member Wyden offered the counter-narrative in its sharpest form. He accused Kennedy of trying to “have it both ways” on vaccines, asserted that the administration was making families sicker and poorer, attacked secret drug-pricing deals, argued TrumpRx offered higher prices than many patients could get through insurance, and said the administration had presided over health-care closures and layoffs after Medicaid cuts. Wyden also accused Kennedy of using his platform to make parents doubt doctors and vaccines.
Finance also produced one of the week’s most heated vaccine-policy exchanges. A senator questioned whether the President had discussed changes to the vaccine charter, then accused Kennedy of creating space for “quacks and conspiracy theorists” and of promoting himself and his own theories over scientific inquiry. Kennedy pushed back, but the exchange illustrated a recurring vulnerability: vaccine governance is not merely one issue among many for his critics; it is the issue that shapes their interpretation of everything else.
The hearing also raised FDA decision-making. Senator Cortez Masto pressed Kennedy on the Replimune RP1 melanoma drug controversy, citing reports that an initial FDA panel recommended approval and that Kennedy had misstated facts about chemotherapy use. Kennedy responded that he had nothing to do with the decision and trusted FDA’s process, but the exchange suggested a second technical vulnerability: when HHS is moving faster and taking a more activist stance at FDA, Congress will probe whether speed, politics, or misunderstood evidence is driving decisions.
The closing exchange with Wyden on TrumpRx was revealing. Wyden demanded details of drug-pricing agreements, while Kennedy accused him of “selective indignation” and tribalism. The chairman then praised Kennedy for handling the hearing well.
Finance showed Kennedy as a combative cabinet secretary who can survive hostile questioning, but not always persuade beyond his base.
Document 07 — April 22, Senate HELP: Science, Vaccines, and the Cassidy Problem
The final hearing, before Senate HELP, had special resonance because Chairman Cassidy is a physician and had been central to Kennedy’s confirmation drama. Cassidy opened in a patient-centered, market-oriented register: getting drugs to patients faster and cheaper, expanding access to generics, lowering R&D costs while maintaining the gold standard, giving money and value to patients, and investing heavily in science to address Alzheimer’s, dementia, and cancer. He also pushed pro-life concerns about abortion drugs and in-person safeguards.
Senator Sanders responded with the opposite frame: the U.S. health system is broken because it spends twice as much per capita as other countries, leaves 85 million uninsured or underinsured, has the highest drug prices, and produces lower life expectancy than peer countries. Sanders then turned directly to vaccines, accusing Kennedy’s HHS of publishing false information suggesting vaccines cause autism, spreading misinformation during the worst measles outbreak in decades, removing the CDC director, and defunding vaccine research.
Kennedy’s prepared statement again returned to the same core script: generational turning point, sickest children in modern history, failed policies, captured systems, drug-pricing agreements, price transparency, prior authorization reform, access to health records, waste/fraud/abuse enforcement, dietary guidelines, and MAHA.
The HELP hearing also included supportive Republican questioning on nutrition, hospital food, ultra-processed food, microplastics, dyes, and the idea that government had ignored root causes of chronic disease until Kennedy forced the issue.
But the most important HELP moment may have been procedural and political rather than substantive. A senator entered into the record a series of articles alleging that Kennedy had broken promises to senators on vaccines and CDC vaccine policy, including references to concerns from Republican senators. This matters because Kennedy’s future does not depend only on Democratic criticism. It depends on whether Republican senators, especially those with medical or institutional commitments to vaccination and science, remain comfortable defending him.
What Was Most Important
The most important takeaway is that Kennedy has successfully made chronic disease prevention the organizing language of HHS. Even critics often conceded the system is broken. Rural health, food quality, ultra-processed foods, microplastics, prevention, prior authorization, and fraud are no longer peripheral topics in these hearings. Kennedy has changed the conversation.
The second major takeaway is that rural health is the bipartisan hinge. Republicans repeatedly praised the $50 billion rural health transformation program, but Democrats and appropriators pressed whether cuts to Medicaid, CDC, HRSA, NIH, diabetes programs, and workforce programs could undercut the same rural communities the administration claims to be saving.
Third, fraud is a strong issue but not a complete governing program. The fraud hearing showed genuine vulnerability in Medicare, hospice, DME, enrollment, and claims systems. But it also showed that Congress wants operational answers: data systems, provider enrollment safeguards, beneficiary remediation, broker oversight, NPI deactivation, and how to avoid collateral damage.
Fourth, vaccine policy dominates Kennedy’s risk profile. In hearing after hearing, critics returned to measles, hepatitis B, CDC recommendations, vaccine-autism claims, ACIP or charter changes, and whether he had broken confirmation promises. Even when Kennedy wanted to talk about food, fraud, or drug prices, vaccines pulled the room back.
What Was Most Concerning
The most concerning feature was Kennedy’s tendency to answer narrow questions with broad philosophy. On contraception, raw milk, hepatitis B testing, Medicaid cuts, diabetes research, and vaccine claims, he often tried to reframe rather than answer. That can work on television; it works less well when appropriators want numbers and authorizers want commitments.
The second concern was the apparent tension between MAHA rhetoric and research cuts. Kennedy says he wants to attack chronic disease at the root. But critics repeatedly cited cuts or disruptions to NIH, CDC, diabetes, mental health, substance-use, vaccine, and public-health programs. Unless HHS can show a clear replacement architecture, the administration risks looking like it is tearing down the very tools needed to study and prevent disease.
The third concern was technical precision. Kennedy is powerful at the 40,000-foot level. But in congressional hearings, a single missing number — the false-negative rate of maternal hepatitis B testing, for example — becomes evidence for critics that he lacks command of mainstream public-health practice.
What Was Most Impressive
Kennedy’s most impressive quality was endurance. Seven hearings in a week, across hostile and friendly committees, is not trivial. He kept his core message consistent and rarely looked lost in the overall architecture of HHS policy.
His second strength was message discipline. The phrases recur: broken system, sickest generation, captured agencies, prevention, real food, rural transformation, fraud, prior authorization, faster approvals, drug pricing. Whether one agrees or not, the message is coherent.
His third strength was that he has found issues that cross old boundaries. Food quality, chronic disease, rural care, prior authorization, fraud, and drug prices are not inherently left or right. A different HHS Secretary might have turned those into consensus themes. Kennedy still might, if he can lower the temperature on vaccines and science governance.
His best single managerial moment was likely the SAMHSA grant reversal: he admitted a mistake, called it an overcorrection, and said he reversed it within 24 hours. That was stronger than many of his more ideological answers.
What Was Weakest
Kennedy’s weakest performance pattern was refusal to give direct assurances. The contraception exchange was a textbook example. Asked for a commitment not to limit access to birth-control methods, he pivoted to maternal health. Whatever the policy truth, the optics were poor.
His second weakness was over-combativeness under pressure. Exchanges with Wyden and others sometimes moved from substantive disagreement to accusations of tribalism or dishonesty. His supporters may enjoy the counterpunching, but it can make him look less like the nation’s chief health officer and more like another combatant in the cable-news pit.
His third weakness was the vaccine albatross. Every policy answer is now heard through that filter. Even when he talks about rural hospitals or drug approvals, critics hear the voice of the nation’s leading vaccine skeptic occupying the nation’s highest health office.
What May Happen Next
The next phase is likely to be less theatrical but more consequential. First, committees will submit questions for the record. Several hearings explicitly left the record open and asked for prompt responses. Given complaints that prior responses took nearly nine months, this will be an early test of whether HHS can improve congressional responsiveness.
Second, appropriators will decide how much of the President’s HHS budget is real and how much is dead on arrival. Senate appropriators from both parties signaled support for NIH, rural health, and substance-use programs, suggesting that Congress may reject or soften many proposed cuts.
Third, vaccine oversight will intensify. Expect more letters, subpoenas, document requests, and possibly hearings focused specifically on CDC vaccine recommendations, advisory committee changes, measles, hepatitis B, and whether Kennedy honored commitments made during confirmation.
Fourth, the drug-pricing deals and TrumpRx will require disclosure or at least structured explanation. Wyden’s demand for details will not go away. If the agreements remain opaque, Democrats will continue calling them sweetheart deals.
Fifth, the fraud agenda may become legislation. Medicare fraud has bipartisan salience, but the real work will be operational: provider enrollment, prepayment analytics, NPI authority, hospice oversight, broker misconduct, and beneficiary protection. Kennedy has a chance to turn rhetoric into durable policy here.
Sidebar: Ten Unexpected or Surprising Takeaways
The week was less about one hearing than about stamina. By the fifth hearing, senators were joking that Kennedy should be “all warmed up.”
Microplastics briefly created a bipartisan opening. DeLauro praised Kennedy’s work on microplastics before pivoting to a ferocious critique of the budget.
Raw milk became a miniature vaccine debate. The issue was not just milk; it was whether HHS should clearly warn the public or merely provide information.
Rural health was Kennedy’s safest bipartisan ground. Even critics had to treat rural access as a central problem.
The fraud hearing was more useful when it stopped being partisan. The victim testimony about Medicare hospice fraud was more powerful than the political speeches.
Kennedy’s best answer was an admission of error. The SAMHSA grant “overcorrection” answer sounded more credible than many polished talking points.
Appropriators were tougher than authorizers in one respect. They wanted program-level budget answers, not MAHA philosophy.
China and biotech emerged as a secondary theme. Kennedy repeatedly argued that China is gaining ground in drugs, trials, IP, and biotech competitiveness.
The phrase “fraud pays” may have more policy life than the hearing itself. It captures the provider-enrollment and prepayment problem in two words.
Kennedy’s Republican problem may matter more than his Democratic problem. Democrats are already opposed; the key question is whether pro-vaccine or institutionally minded Republicans begin to peel away.
Sidebar: Five Moments of Humor — or Something Resembling Humor
“All warmed up.” At the Senate Appropriations hearing, Chair Capito noted that it was Kennedy’s fifth of seven hearings, so he should be “all warmed up.” It was gentle, but in a week like this, gentle counted.
Dunkin’ Donuts diplomacy. Ranking Member Neal, after invoking the Kennedy family and Massachusetts health care, added that Massachusetts also likes Dunkin’ Donuts coffee. It was a small regional olive branch before the hammer came down.
“Vote for me. I’m for more fraud.” Neal’s line that no candidate campaigns on supporting fraud was funny because it was true — and because it punctured the easy politics of anti-fraud rhetoric.
The gavel needed encouragement. The Senate Appropriations hearing opened with the chair saying, “Guess I had to hit that a little harder. Hint, hint, didn’t work.” Congressional comedy rarely soars, but gavels have feelings too.
“That’s why our country is screwed.” In the fraud hearing, a member’s exasperated reaction to a witness declining to answer an eligibility question was not exactly humor, but it had the bleak comic timing of modern congressional theater.
